期刊文献+

乌体林斯联合布地奈德防治毛细支气管炎后哮喘的临床观察 被引量:2

Utilin′s combined with Budesonide in the prevention and treatment of asthma following bronchiolitis
下载PDF
导出
摘要 目的:观察应用乌体林斯联合布地奈德降低毛细支气管炎后哮喘发病率,寻找更好的治疗和预防小儿毛细支气管炎发展成哮喘的方法。方法:61例确诊毛细支气管炎的患儿随机分成防治组(n=31)和对照组(n=30),两组均吸入布地奈德气雾剂100μg/次,2次/d,2个月后减量至100μg/(次.d),维持1个月后停药。防治组加乌体林斯肌内注射1.72μg/次,1次/周,共用10次,临床随访1年,观察1年内每组哮喘的发生率。结果:防治组与对照组的哮喘发生率差异有统计学意义(P<0.05)。结论:应用乌体林斯联合布地奈德可明显降低毛细支气管炎后哮喘的发病率。 Objective To observe the effects of Utilin′s combined with Budesonide decreasing the incidence of asthma following bronchiolitis and find a better way of curing and preventing bronchiolitis developing into asthma.Method Total 61 cases with bronchiolitis were randomly divided into two groups:the treatment group(n=31)and the control group(n=30).Budesonide Aerosol was inhaled by all cases(100 μg every time and two times everyday).Two months later,Budesonide Aerosol was inhaled 100 μg everyday and a month later withdrawal.Besides in the treatment group 1.72 μg Utilin′s was injected every time and 1 time/week,in total ten times.The cases were followed for a year and the incidence of asthma was oberved.Results The incidence of asthma was significantly lower in the treatment group than that of the control group(P0.05).Conclusion Utilin′s combined with Budesonide can obviously decrease the incidence of asthma following bronchiolitis.
作者 刘继国
出处 《吉林医学》 CAS 2011年第31期6602-6603,共2页 Jilin Medical Journal
关键词 毛细支气管炎 哮喘 乌体林斯 布地奈德 Bronchiolitis Asthma Utilin′s Budesonide
  • 相关文献

参考文献3

二级参考文献16

  • 1Behzman RE, Kilegman RM, Arvin AM, et al. Nelson Textbook of Pediatrics, 16th ed. Philadelphia: WB Saunders Co, 2000 : 1285- 1287.
  • 2Martinez FD, Stern DA, Wright AL, et al. Differential immune responses to acute lower respiratory illness in early life by subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol, 1998, 102 : 915- 920.
  • 3Bisgaard H, Mauck SL, Nielsen JP, et al. Inhaled badesonide for treatment of recurrent wheezing in early childhood. Lancet,1990, 336 : 649 - 651.
  • 4Wamer JA. Primary sensitization in infants.Ann Allergy Asthma Immunol, 1999, 83 : 426 - 429.
  • 5Tovey E, Marks G. Methods and effectiveness of environmental control.J Allergy Clin Immunol, 1999, 103 : 179- 191.
  • 6Parmonchi PA, Bauguolo F, Sampognaro S, et al. Genetic and environmental factors contributing to the onset of allergic disorders. Int Arch Allergy Immunol, 2000, 121 : 2- 9.
  • 7Gustafsson P, Tsanalas J, Gold M, et al. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/ day with inhaled beclomethasone dipropionate 400 micrograms/ day in mild and moderate asthma. Arch Dis Child,1993, 69 : 206 - 211.
  • 8Turktas I, Ozkaya O, Bostanci I, et al. Safety of inhaled corticosteroid therapy in young children with asthma. Ann Allergy Asthma Immunol, 2001 Jun, 86(6) : 649- 654.
  • 9Lonky SA, Tis GM. Determinging changes in airway caliber in asthma: The role of submaximal expiratory flow rate. Chest, 1980,77(6) : 741-744.
  • 10Erb KJ, Holloway JW, Sobeck A, et al. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin(BCG) suppresses allergen-induced airway eosinophilia.J Exp Med,1998, 4 : 561 - 569.

共引文献2755

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部